Results of a survey of pediatricians' practice patterns for children with vesicoureteral reflux (VUR) are worrisome in showing these primary care practitioners are retaining their patients longer before referring them to a specialist.
Radiologically proven VUR was present in 11 mothers and seven fathers as well as in 36 second-degree relatives (aunts, uncles, grandparents) and 73 third-degree relatives (65 first cousins and eight great-aunts, -uncles or -grandparents) of 259 VUR patients in an Irish study.
Results of a retrospective study investigating risk factors for the development of renal parenchymal damage in young children with primary high-grade vesicoureteral reflux (VUR) underscore the importance of early detection and treatment to prevent renal damage or its progression from ongoing VUR.
Use of Dx/HA (Deflux) for the treatment of vesicoureteral reflux (VUR) in children increased rapidly after it gained FDA approval. Despite high rates of utilization and positive early findings, more recent reports are raising questions about long-term outcomes and prompting further research.
Downgrading of high-grade vesicoureteral reflux (VUR) after endoscopic treatment performed because of breakthrough urinary tract infections results in cessation of febrile UTIs and, often, spontaneous VUR resolution as well.